Endurant Capital Management LP - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$1,091,000
-19.5%
46,929
-44.9%
0.47%
-6.7%
Q1 2018$1,356,000
+513.6%
85,200
+326.0%
0.51%
+614.1%
Q1 2017$221,000
-59.8%
20,000
-10.7%
0.07%
-65.2%
Q3 2016$550,000
-31.9%
22,400
-44.1%
0.20%
-24.4%
Q2 2016$808,000
+127.6%
40,100
+197.0%
0.27%
+134.8%
Q1 2016$355,000
-55.2%
13,500
+73.1%
0.12%
-56.6%
Q4 2015$793,000
-61.3%
7,800
-32.2%
0.26%
-61.3%
Q3 2015$2,051,000
-54.1%
11,500
-42.8%
0.68%
-48.0%
Q2 2015$4,465,000
+2.2%
20,100
-8.6%
1.32%
-8.7%
Q1 2015$4,370,000
+59.0%
22,000
+14.6%
1.44%
+34.0%
Q4 2014$2,748,00019,2001.08%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2016
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders